The personalized medicine for diabetes meeting summary report

Journal of Diabetes Science and Technology

Volumn 3, Issue 4, 2009, Pages 677-679

  Klonoff, David C ^a  

^a Mills Peninsula Health Services   (United States)

Author keywords

Biomarkers; Diabetes; Genetics; Genomics; Personalized; Therapy

Indexed keywords

EDITORIAL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; RESEARCH;

DIABETES MELLITUS, TYPE 2; HUMANS; INDIVIDUALIZED MEDICINE; RESEARCH;

EID: 77953064010     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300410     Document Type: Conference Paper

References (19)

1. Klonoff DC. Personalized medicine for diabetes. J Diabetes Sci Technol. 2008;2(3):335-41.
2. Abrahams E, Silver M. The case for personalized medicine. J Diabetes Sci Technol. 2009;3(4):680-4.
3. Elbein SC. Genetics factors contributing to type 2 diabetes across ethnicities. J Diabetes Sci Technol. 2009;3(4):685-9.
4. Florez JC. Genetic susceptibility to type 2 diabetes and implications for therapy. J Diabetes Sci Technol. 2009;3(4):690-6.
5. Roberts CK, Liu S. Effects of glycemic load on metabolic health and type 2 diabetes mellitus. J Diabetes Sci Technol. 2009;3(4):697-704.
6. Vella A. Pharmacogenetics for type 2 diabetes: practical considerations for study design. J Diabetes Sci Technol. 2009;3(4):705-9.
7. Wise C, Kaput J. A strategy for analyzing gene-nutrient interactions in type 2 diabetes. J Diabetes Sci Technol. 2009;3(4):710-21.
8. Valdez R. Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol. 2009;3(4):722-6.
9. Ershow AG. Environmental influences on development of type 2 diabetes and obesity: prevention and management. J Diabetes Sci Technol. 2009;3(4):727-34.
10. Mueller PW. Technologies for diabetes genomics. J Diabetes Sci Technol. 2009;3(4):735-8.
11. Harper CC. Personalized medicine in diabetes: regulatory considerations. J Diabetes Sci Technol. 2009;3(4):739-42.
12. True MW. Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine. J Diabetes Sci Technol. 2009;3(4):743-7.
13. Urdea M, Kolberg J, Wilber J, Gerwien R, Moler E, Rowe M, Jorgensen P, Hansen T, Pedersen O, Jørgensen T, Borch-Johnsen K. Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6,784 Danish people (Inter99):. J Diabetes Sci Technol. 2009;3(4):748-52.
14. Marrero DG. The prevention of type 2 diabetes: an overview. J Diabetes Sci Technol. 2009;3(4):756-60.
15. Friedl KE. Waist circumference threshold values for type 2 diabetes risk. J Diabetes Sci Technol. 2009;3(4):761-9
16. Lott L. A genomics study of type 2 diabetes mellitus in U.S. Air Force personnel. J Diabetes Sci Technol. 2009;3(4):770-5.
17. Ediger MN, Olson BP, Maynard JD. Noninvasive optical screening for diabetes. J Diabetes Sci Technol. 2009;3(4):776-80.
18. Haga SB. Ethical issues of predictive genetic testing for diabetes. J Diabetes Sci Technol. 2009;3(4):781-8.
19. Healy B. Med school's hot new field: personalized medicine. US News and World Report. 2008 Mar 26. Available from: http://health.usnews.com/articles/ health/2008/03/26/med-schools-hot-new-field-personalized-medicine.html? loomia-ow=t0:s0:a41:g2:r2:c0.170406:b20239797:z0&s-cid=loomia:personalized- medicine.